扩大查成功率以减少大动脉动脉瘤死亡率:进展解释和新的前沿
Nobel Chenggong Zong1, Kai Huang1, Xia Yang2
1Division of Molecular Medicine, Department of Anesthesiology and Perioperative Medicine, Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Trends in cardiovascular medicine
|December 15, 2024
概括
大动脉动脉瘤查计划减少了死亡,新的生物标志物和口服药物提供了扩大治疗选择. 持续的承诺和创新对于未来成功打击这种致命疾病至关重要.
科学领域:
- 心血管医学 心血管医学
- 公共卫生 公共卫生
- 医学诊断 医学诊断 医学诊断
背景情况:
- 大动脉动脉瘤是全球突发死亡的重要原因,通常在破裂之前无症状.
- 2005年美国预防服务工作组 (USPST) 启动的全国性查计划,并被其他国家采用,导致流行率和死亡率有所下降.
- 二十年的实践已经在诊断,手术技术和药物治疗大动脉动脉瘤方面取得了实质性的进步.
研究的目的:
- 审查大动脉动脉瘤查计划的历史和演变.
- 分析大动脉动脉瘤管理的进展,挑战和未来方向.
- 突出新兴技术和治疗策略,用于更广泛的人口查和治疗.
主要方法:
- 历史数据和队列研究的审查导致查计划的启动.
- 分析实施进展情况,包括收益,差距和争议.
- 评估新的诊断技术,手术方法和药理选择.
主要成果:
- 查计划有助于腹腔大动脉动脉瘤 (AAA) 患病率和死亡率的显著下降.
- 进步包括新的诊断工具,改进的外科手术结果,以及小动脉瘤的新型口服药物.
- 甲基生物素 (H4B) 生物标志物测定提供了可访问和高通量查能力.
结论:
- 大动脉动脉瘤查计划已经取得了成功,但需要持续的适应和创新.
- 扩大查和治疗选择,包括基于生物标志物的测试和口服药物,是必不可少的.
- 应对人口变化和COVID-19后影响等挑战,需要敏捷的项目管理和技术整合.
关键词:
腹腔大动脉动脉瘤 腹腔大动脉动脉瘤生物标志物生物标志物经济效益性 经济效益性诊断 诊断 诊断 诊断埃瓦尔·埃瓦尔 (Evar Evar) 是一个人.死亡率 死亡率 死亡率预防性医学是一种预防性医学.查检查 查检查 查检查吸烟 吸烟 吸烟 吸烟监督 监督 监督 监督 监督 监督胸前大动脉动脉瘤 胸前大动脉动脉瘤美国邮政服务局 (USPST)超声波学 超声波学 超声波学更多相关视频
相关概念视频
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


